Democracy Dies in Darkness
A groundbreaking vaccine for acute myeloid leukemia has successfully reduced the risk of death in certain patients. This finding comes from a Phase 3 clinical trial.
Sellas Life Sciences, in collaboration with Memorial Sloan Kettering Cancer Center, reported their success on Tuesday. This achievement is part of a significant year for advancements in cancer vaccines.
Acute myeloid leukemia is a severe form of blood cancer. Effective treatments have been a challenge, but this vaccine shows promise in improving patient outcomes.

Highlights from Recent News Stories
DEA Dismantles First U.S. Large-Scale Nitazene Lab
Trump Open to Bipartisan Health Care Plan with Democrats
Ty Pennington’s View on Home Renovation and Health
Building Resilience Amid Stress and Uncertainty
How to Prepare for Aging Parents: Practical Steps for Families